NUV-868

· Nuvation Bio

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NUV-868, covering 2025-11-06 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors [Phase 1]

See pricing